BeStock  
Stocks › Biotechnology › AURA

Aura Biosciences AURA

US equityMarket cap rank #3539Biotechnology
$6.46 +$0.29 (+4.70%)
Pre-market · Oct 8, 8:10 am ET · After hours $6.46 0.00%
Open$6.10
Prev close$6.17
Day range$6.10 – $6.56
Volume723.7K
Market cap$669.93M
P/E (TTM)–
Dividend yield–

Fundamentals

Latest reported quarter: Q2, ended Jun 2026

Revenue$0.00
Operating profit-$48.07M-68.0% YoY
Net profit-$45.64M-68.9% YoY
Diluted EPS-$0.48-2.1% YoY
Free cash flow-$32.52M-56.3% YoY
Operating cash flow-$32.50M

Revenue, last 8 quarters

$0.0Sep '24$0.0Dec '24$0.0Mar '25$0.0Jun '25$0.0Sep '25$0.0Dec '25$0.0Mar '26$0.0Jun '26

Net profit, last 8 quarters

$-21.0MSep '24$-25.8MDec '24$-27.5MMar '25$-27.0MJun '25$-26.1MSep '25$-25.6MDec '25$-33.7MMar '26$-45.6MJun '26

Diluted EPS by quarter

-0.42Sep '24-0.52Dec '24-0.55Mar '25-0.47Jun '25-0.40Sep '25-0.37Dec '25-0.50Mar '26-0.48Jun '26

Free cash flow by quarter

$-15.6MSep '24$-24.3MDec '24$-23.5MMar '25$-20.8MJun '25$-20.2MSep '25$-20.6MDec '25$-30.0MMar '26$-32.5MJun '26

Annual revenue

$0.0FY20$0.0FY21$0.0FY22$0.0FY23$0.0FY24$0.0FY25

Profitability & balance sheet

Return on equity-53.5%
Return on assets-47.4%
Return on invested capital-51.5%
Current ratio16.82
Liabilities / assets9.4%
Cash & investments$323.84M
Total debt$13.30M
Net cash (debt)$310.54M

Income statement

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Operating Revenue $0.00 $0.00 $0.00 $0.00 $0.00
Operating Expense $48.07M $34.87M $112.79M $27.24M $27.91M
Selling and Admin Expenses $17.32M $6.91M $22.49M $5.34M $5.73M
-General & Admin Expense $17.32M $6.91M $22.49M $5.34M $5.73M
Research & Development $30.75M $27.96M $90.30M $21.90M $22.18M
Operating Profit -$48.07M -$34.87M -$112.79M -$27.24M -$27.91M
Net Non-Operating Interest Income (Expense) $2.31M $1.19M $6.63M $1.54M $1.82M
Non-Operating Interest Income $2.31M $1.19M $6.63M $1.54M $1.82M
Other Income (Expense) $154,000.00 $2,000.00 $77,000.00 $149,000.00 -$13,000.00
Other Non-Operating Income (Expenses) $154,000.00 $2,000.00 $77,000.00 $149,000.00 -$13,000.00
Pretax Profit -$45.61M -$33.67M -$106.08M -$25.54M -$26.10M
Tax $29,000.00 $11,000.00 $108,000.00 $15,000.00 $26,000.00
Net Profit -$45.64M -$33.69M -$106.19M -$25.56M -$26.13M
Profit from Continuing Operations -$45.64M -$33.69M -$106.19M -$25.56M -$26.13M
Net Income to Parent Company -$45.64M -$33.69M -$106.19M -$25.56M -$26.13M
Net Income to Common Stockholders -$45.64M -$33.69M -$106.19M -$25.56M -$26.13M
Basic EPS -$0.48 -$0.50 -$1.76 -$0.37 -$0.40
Diluted EPS -$0.48 -$0.50 -$1.76 -$0.37 -$0.40

Balance sheet

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Total Assets $348.13M $137.68M $169.43M $169.43M $190.02M
Total Current Assets $329.03M $118.50M $149.74M $149.74M $170.12M
Cash and Cash Equivalents & Short-Term Investments $323.84M $114.73M $144.24M $144.24M $161.87M
-Cash and Cash Equivalents $67.84M $84.79M $59.52M $59.52M $47.55M
-Short Term Investments $256.00M $29.94M $84.73M $84.73M $114.31M
Receivables $1.76M – – – –
-Accrued Interest Receivable $1.76M – – – –
Prepaid Assets $2.61M $2.71M $4.32M $4.32M $5.67M
Other Current Assets $819,000.00 $1.06M $1.18M $1.18M $2.59M
Total Non-Current Assets $19.10M $19.17M $19.69M $19.69M $19.90M
Net PPE $17.19M $17.89M $18.45M $18.45M $18.86M
-Gross PPE $24.77M $25.21M $25.50M $25.50M $25.70M
-Accumulated Depreciation -$7.57M -$7.33M -$7.05M -$7.05M -$6.84M
Other Non-Current Assets $1.91M $1.29M $1.24M $1.24M $1.05M
Total Liabilities $32.86M $30.43M $32.52M $32.52M $33.36M
Total Current Liabilities $19.56M $16.71M $18.38M $18.38M $18.82M
Payables $2.25M $2.57M $1.55M $1.55M $1.89M
-Accounts Payable $2.25M $2.57M $1.55M $1.55M $1.89M
Current Accrued Expenses $8.50M $7.90M $7.34M $7.34M $7.46M
Short-Term Debt and Capital Lease Obligation $3.29M $3.27M $3.24M $3.24M $3.22M
-Current Capital Lease Obligation $3.29M $3.27M $3.24M $3.24M $3.22M
Other Current Liabilities $908,000.00 $378,000.00 $242,000.00 $242,000.00 $152,000.00
Total Non-Current Liabilities $13.30M $13.72M $14.13M $14.13M $14.53M
Long Term Debt and Capital Lease Obligation $13.30M $13.72M $14.13M $14.13M $14.53M
-Long Term Capital Lease Obligation $13.30M $13.72M $14.13M $14.13M $14.53M
Total Equity $315.27M $107.25M $136.91M $136.91M $156.67M
Stockholders' Equity $315.27M $107.25M $136.91M $136.91M $156.67M
Capital Stock $1,000.00 $0.00 $0.00 $0.00 $0.00
-Common Stock $1,000.00 $0.00 $0.00 $0.00 $0.00
Additional Paid-In Capital $914.77M $621.56M $617.43M $617.43M $611.46M
Retained Earnings -$559.74M -$514.10M -$480.42M -$480.42M -$454.86M
Less: Treasury Stock $39.09M – – – –
Gains/Losses Not Affecting Retained Earnings -$670,000.00 -$207,000.00 -$102,000.00 -$102,000.00 $69,000.00

Cash flow

Line item 2026 Q2 2026 Q1 2025 ANNUAL 2025 Q4 2025 Q3
Operating Cash Flow -$32.50M -$29.89M -$84.74M -$20.47M -$20.14M
Net cash flow from continuing operations -$32.50M -$29.89M -$84.74M -$20.47M -$20.14M
Net Income from Continuing Operations -$45.64M -$33.69M -$106.19M -$25.56M -$26.13M
Depreciation & Depletion & Amortization $260,000.00 $274,000.00 $1.13M $272,000.00 $280,000.00
Other Non-Cash Items $442,000.00 $412,000.00 $1.58M $402,000.00 $392,000.00
Change in Working Capital $406,000.00 -$426,000.00 $5.97M $1.56M $1.96M
-Change in Prepaid Assets -$1.42M $1.73M $4.03M $2.68M -$1.53M
-Change in Payables and Accrued Expense $2.84M -$1.72M $3.29M -$554,000.00 $3.95M
-Change in Other Current Assets -$622,000.00 -$46,000.00 $47,000.00 -$194,000.00 -$92,000.00
-Change in Other Current Liabilities -$397,000.00 -$386,000.00 -$1.39M -$377,000.00 -$358,000.00
Net cash flow from investing -$226.04M $54.90M $35.60M $29.82M -$44.02M
Net Cash Flow from Continuing Investing Activities -$226.04M $54.90M $35.60M $29.82M -$44.02M
Net PPE Purchase and Sale -$21,000.00 -$102,000.00 -$447,000.00 -$176,000.00 -$45,000.00
Net Investment Purchase and Sale -$226.01M $55.00M $36.04M $30.00M -$43.97M
Financing Cash Flow $241.75M $300,000.00 $77.16M $2.77M $4.36M
Net Cash Flow from Continuing Financing Activities $241.75M $300,000.00 $77.16M $2.77M $4.36M
Proceeds from Stock Option Exercised $21.34M $300,000.00 $24.58M $0.00 $1.08M
Ending Cash Balance $68.60M $85.56M $60.28M $60.28M $48.32M
Net Change in Cash -$16.78M $25.31M $28.01M $12.12M -$59.80M
Beginning Cash Balance $85.56M $60.28M $32.46M $48.32M $108.14M
Effect of Exchange Rate Changes -$173,000.00 -$27,000.00 -$186,000.00 -$160,000.00 -$14,000.00
Free Cash Flow -$32.52M -$30.00M -$85.19M -$20.65M -$20.19M
Net Common Stock Issuance – – $52.57M $2.77M $3.29M

Discussion

No comments yet — be the first to weigh in on AURA.

Leave a comment

Scroll to Top